nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—AHR—liver cancer	0.561	0.761	CbGaD
Mexiletine—CYP2E1—liver cancer	0.176	0.239	CbGaD
Mexiletine—CYP2B6—Sorafenib—liver cancer	0.0392	0.289	CbGbCtD
Mexiletine—CYP2B6—Doxorubicin—liver cancer	0.0238	0.175	CbGbCtD
Mexiletine—CYP1A2—Sorafenib—liver cancer	0.023	0.169	CbGbCtD
Mexiletine—CYP2D6—Sorafenib—liver cancer	0.0189	0.14	CbGbCtD
Mexiletine—CYP3A4—Sorafenib—liver cancer	0.012	0.0887	CbGbCtD
Mexiletine—CYP2D6—Doxorubicin—liver cancer	0.0115	0.0846	CbGbCtD
Mexiletine—CYP3A4—Doxorubicin—liver cancer	0.0073	0.0538	CbGbCtD
Mexiletine—Cardiogenic shock—Epirubicin—liver cancer	0.00197	0.0372	CcSEcCtD
Mexiletine—Cardiogenic shock—Doxorubicin—liver cancer	0.00182	0.0344	CcSEcCtD
Mexiletine—Oesophageal ulcer—Epirubicin—liver cancer	0.00113	0.0214	CcSEcCtD
Mexiletine—Oesophageal ulcer—Doxorubicin—liver cancer	0.00105	0.0198	CcSEcCtD
Mexiletine—Cardiac failure congestive—Sorafenib—liver cancer	0.000894	0.0169	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Sorafenib—liver cancer	0.000859	0.0162	CcSEcCtD
Mexiletine—Dry skin—Sorafenib—liver cancer	0.000743	0.014	CcSEcCtD
Mexiletine—Dysphagia—Sorafenib—liver cancer	0.000701	0.0132	CcSEcCtD
Mexiletine—Pancreatitis—Sorafenib—liver cancer	0.000687	0.013	CcSEcCtD
Mexiletine—Abdominal discomfort—Sorafenib—liver cancer	0.000672	0.0127	CcSEcCtD
Mexiletine—Neutropenia—Sorafenib—liver cancer	0.000655	0.0124	CcSEcCtD
Mexiletine—Erectile dysfunction—Sorafenib—liver cancer	0.000646	0.0122	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00062	0.0117	CcSEcCtD
Mexiletine—Nystagmus—Epirubicin—liver cancer	0.000578	0.0109	CcSEcCtD
Mexiletine—Ventricular arrhythmia—Epirubicin—liver cancer	0.000558	0.0105	CcSEcCtD
Mexiletine—Nystagmus—Doxorubicin—liver cancer	0.000535	0.0101	CcSEcCtD
Mexiletine—Erythema multiforme—Sorafenib—liver cancer	0.00053	0.01	CcSEcCtD
Mexiletine—Tinnitus—Sorafenib—liver cancer	0.000523	0.00987	CcSEcCtD
Mexiletine—Ventricular arrhythmia—Doxorubicin—liver cancer	0.000516	0.00974	CcSEcCtD
Mexiletine—Arrhythmia—Sorafenib—liver cancer	0.000501	0.00946	CcSEcCtD
Mexiletine—Alopecia—Sorafenib—liver cancer	0.000496	0.00936	CcSEcCtD
Mexiletine—Blood disorder—Epirubicin—liver cancer	0.000494	0.00933	CcSEcCtD
Mexiletine—Dysgeusia—Sorafenib—liver cancer	0.000478	0.00903	CcSEcCtD
Mexiletine—Muscle spasms—Sorafenib—liver cancer	0.00047	0.00886	CcSEcCtD
Mexiletine—Blood disorder—Doxorubicin—liver cancer	0.000457	0.00863	CcSEcCtD
Mexiletine—Ventricular extrasystoles—Epirubicin—liver cancer	0.000457	0.00863	CcSEcCtD
Mexiletine—Syncope—Sorafenib—liver cancer	0.000438	0.00827	CcSEcCtD
Mexiletine—Leukopenia—Sorafenib—liver cancer	0.000437	0.00825	CcSEcCtD
Mexiletine—Loss of consciousness—Sorafenib—liver cancer	0.000429	0.0081	CcSEcCtD
Mexiletine—Atrioventricular block—Epirubicin—liver cancer	0.000426	0.00804	CcSEcCtD
Mexiletine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.000423	0.00798	CcSEcCtD
Mexiletine—Hypertension—Sorafenib—liver cancer	0.000422	0.00796	CcSEcCtD
Mexiletine—Coordination abnormal—Epirubicin—liver cancer	0.00042	0.00794	CcSEcCtD
Mexiletine—Arthralgia—Sorafenib—liver cancer	0.000416	0.00785	CcSEcCtD
Mexiletine—Hiccups—Epirubicin—liver cancer	0.000413	0.00779	CcSEcCtD
Mexiletine—Dry mouth—Sorafenib—liver cancer	0.000407	0.00768	CcSEcCtD
Mexiletine—Atrioventricular block—Doxorubicin—liver cancer	0.000394	0.00743	CcSEcCtD
Mexiletine—Shock—Sorafenib—liver cancer	0.000392	0.0074	CcSEcCtD
Mexiletine—Thrombocytopenia—Sorafenib—liver cancer	0.00039	0.00737	CcSEcCtD
Mexiletine—Coordination abnormal—Doxorubicin—liver cancer	0.000389	0.00734	CcSEcCtD
Mexiletine—Hiccups—Doxorubicin—liver cancer	0.000382	0.00721	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000363	0.00686	CcSEcCtD
Mexiletine—Dyspnoea—Sorafenib—liver cancer	0.000355	0.00671	CcSEcCtD
Mexiletine—Dyspepsia—Sorafenib—liver cancer	0.000351	0.00662	CcSEcCtD
Mexiletine—Fatigue—Sorafenib—liver cancer	0.000344	0.00649	CcSEcCtD
Mexiletine—Pain—Sorafenib—liver cancer	0.000341	0.00643	CcSEcCtD
Mexiletine—Constipation—Sorafenib—liver cancer	0.000341	0.00643	CcSEcCtD
Mexiletine—Cardiac failure congestive—Epirubicin—liver cancer	0.00033	0.00624	CcSEcCtD
Mexiletine—Gastrointestinal pain—Sorafenib—liver cancer	0.000326	0.00615	CcSEcCtD
Mexiletine—Hot flush—Epirubicin—liver cancer	0.00032	0.00605	CcSEcCtD
Mexiletine—Menopausal symptoms—Epirubicin—liver cancer	0.000318	0.006	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000318	0.006	CcSEcCtD
Mexiletine—Abdominal pain—Sorafenib—liver cancer	0.000315	0.00595	CcSEcCtD
Mexiletine—Body temperature increased—Sorafenib—liver cancer	0.000315	0.00595	CcSEcCtD
Mexiletine—Cardiac failure congestive—Doxorubicin—liver cancer	0.000306	0.00577	CcSEcCtD
Mexiletine—Hot flush—Doxorubicin—liver cancer	0.000296	0.0056	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000294	0.00555	CcSEcCtD
Mexiletine—Menopausal symptoms—Doxorubicin—liver cancer	0.000294	0.00555	CcSEcCtD
Mexiletine—Hypersensitivity—Sorafenib—liver cancer	0.000294	0.00554	CcSEcCtD
Mexiletine—Asthenia—Sorafenib—liver cancer	0.000286	0.0054	CcSEcCtD
Mexiletine—Ataxia—Epirubicin—liver cancer	0.000282	0.00532	CcSEcCtD
Mexiletine—Liver function test abnormal—Epirubicin—liver cancer	0.000277	0.00522	CcSEcCtD
Mexiletine—Dry skin—Epirubicin—liver cancer	0.000275	0.00519	CcSEcCtD
Mexiletine—Diarrhoea—Sorafenib—liver cancer	0.000273	0.00515	CcSEcCtD
Mexiletine—Dizziness—Sorafenib—liver cancer	0.000264	0.00498	CcSEcCtD
Mexiletine—Ataxia—Doxorubicin—liver cancer	0.000261	0.00492	CcSEcCtD
Mexiletine—Dysphagia—Epirubicin—liver cancer	0.000259	0.00489	CcSEcCtD
Mexiletine—Liver function test abnormal—Doxorubicin—liver cancer	0.000256	0.00483	CcSEcCtD
Mexiletine—Dry skin—Doxorubicin—liver cancer	0.000254	0.0048	CcSEcCtD
Mexiletine—Pancreatitis—Epirubicin—liver cancer	0.000254	0.00479	CcSEcCtD
Mexiletine—Vomiting—Sorafenib—liver cancer	0.000253	0.00478	CcSEcCtD
Mexiletine—Angina pectoris—Epirubicin—liver cancer	0.000252	0.00476	CcSEcCtD
Mexiletine—Rash—Sorafenib—liver cancer	0.000251	0.00474	CcSEcCtD
Mexiletine—Dermatitis—Sorafenib—liver cancer	0.000251	0.00474	CcSEcCtD
Mexiletine—Headache—Sorafenib—liver cancer	0.00025	0.00471	CcSEcCtD
Mexiletine—Neutropenia—Epirubicin—liver cancer	0.000242	0.00457	CcSEcCtD
Mexiletine—Dysphagia—Doxorubicin—liver cancer	0.00024	0.00452	CcSEcCtD
Mexiletine—Nausea—Sorafenib—liver cancer	0.000237	0.00447	CcSEcCtD
Mexiletine—Pancreatitis—Doxorubicin—liver cancer	0.000235	0.00444	CcSEcCtD
Mexiletine—Angina pectoris—Doxorubicin—liver cancer	0.000233	0.00441	CcSEcCtD
Mexiletine—Drowsiness—Epirubicin—liver cancer	0.000231	0.00436	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000229	0.00432	CcSEcCtD
Mexiletine—Neutropenia—Doxorubicin—liver cancer	0.000224	0.00423	CcSEcCtD
Mexiletine—Agranulocytosis—Epirubicin—liver cancer	0.000216	0.00407	CcSEcCtD
Mexiletine—Drowsiness—Doxorubicin—liver cancer	0.000214	0.00403	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000212	0.004	CcSEcCtD
Mexiletine—Bradycardia—Epirubicin—liver cancer	0.000211	0.00398	CcSEcCtD
Mexiletine—Hepatitis—Epirubicin—liver cancer	0.000207	0.00391	CcSEcCtD
Mexiletine—Hypoaesthesia—Epirubicin—liver cancer	0.000206	0.00389	CcSEcCtD
Mexiletine—Pharyngitis—Epirubicin—liver cancer	0.000206	0.00388	CcSEcCtD
Mexiletine—Visual impairment—Epirubicin—liver cancer	0.0002	0.00377	CcSEcCtD
Mexiletine—Agranulocytosis—Doxorubicin—liver cancer	0.000199	0.00376	CcSEcCtD
Mexiletine—Erythema multiforme—Epirubicin—liver cancer	0.000196	0.0037	CcSEcCtD
Mexiletine—Bradycardia—Doxorubicin—liver cancer	0.000195	0.00369	CcSEcCtD
Mexiletine—Tinnitus—Epirubicin—liver cancer	0.000193	0.00365	CcSEcCtD
Mexiletine—Hepatitis—Doxorubicin—liver cancer	0.000192	0.00362	CcSEcCtD
Mexiletine—Hypoaesthesia—Doxorubicin—liver cancer	0.000191	0.0036	CcSEcCtD
Mexiletine—Pharyngitis—Doxorubicin—liver cancer	0.00019	0.00359	CcSEcCtD
Mexiletine—Arrhythmia—Epirubicin—liver cancer	0.000185	0.0035	CcSEcCtD
Mexiletine—Visual impairment—Doxorubicin—liver cancer	0.000185	0.00349	CcSEcCtD
Mexiletine—Alopecia—Epirubicin—liver cancer	0.000183	0.00346	CcSEcCtD
Mexiletine—Erythema multiforme—Doxorubicin—liver cancer	0.000181	0.00342	CcSEcCtD
Mexiletine—Tinnitus—Doxorubicin—liver cancer	0.000179	0.00338	CcSEcCtD
Mexiletine—Tension—Epirubicin—liver cancer	0.000177	0.00334	CcSEcCtD
Mexiletine—Dysgeusia—Epirubicin—liver cancer	0.000177	0.00334	CcSEcCtD
Mexiletine—Nervousness—Epirubicin—liver cancer	0.000175	0.00331	CcSEcCtD
Mexiletine—Muscle spasms—Epirubicin—liver cancer	0.000174	0.00328	CcSEcCtD
Mexiletine—Arrhythmia—Doxorubicin—liver cancer	0.000171	0.00324	CcSEcCtD
Mexiletine—Vision blurred—Epirubicin—liver cancer	0.00017	0.00321	CcSEcCtD
Mexiletine—Alopecia—Doxorubicin—liver cancer	0.00017	0.0032	CcSEcCtD
Mexiletine—Ill-defined disorder—Epirubicin—liver cancer	0.000167	0.00316	CcSEcCtD
Mexiletine—Tension—Doxorubicin—liver cancer	0.000164	0.00309	CcSEcCtD
Mexiletine—Dysgeusia—Doxorubicin—liver cancer	0.000164	0.00309	CcSEcCtD
Mexiletine—Malaise—Epirubicin—liver cancer	0.000163	0.00307	CcSEcCtD
Mexiletine—Nervousness—Doxorubicin—liver cancer	0.000162	0.00306	CcSEcCtD
Mexiletine—Syncope—Epirubicin—liver cancer	0.000162	0.00306	CcSEcCtD
Mexiletine—Leukopenia—Epirubicin—liver cancer	0.000162	0.00305	CcSEcCtD
Mexiletine—Muscle spasms—Doxorubicin—liver cancer	0.000161	0.00303	CcSEcCtD
Mexiletine—Palpitations—Epirubicin—liver cancer	0.000159	0.00301	CcSEcCtD
Mexiletine—Loss of consciousness—Epirubicin—liver cancer	0.000159	0.00299	CcSEcCtD
Mexiletine—Vision blurred—Doxorubicin—liver cancer	0.000157	0.00297	CcSEcCtD
Mexiletine—Convulsion—Epirubicin—liver cancer	0.000156	0.00295	CcSEcCtD
Mexiletine—Hypertension—Epirubicin—liver cancer	0.000156	0.00294	CcSEcCtD
Mexiletine—Ill-defined disorder—Doxorubicin—liver cancer	0.000155	0.00293	CcSEcCtD
Mexiletine—Chest pain—Epirubicin—liver cancer	0.000154	0.0029	CcSEcCtD
Mexiletine—Arthralgia—Epirubicin—liver cancer	0.000154	0.0029	CcSEcCtD
Mexiletine—Discomfort—Epirubicin—liver cancer	0.000152	0.00287	CcSEcCtD
Mexiletine—Malaise—Doxorubicin—liver cancer	0.000151	0.00284	CcSEcCtD
Mexiletine—Dry mouth—Epirubicin—liver cancer	0.00015	0.00284	CcSEcCtD
Mexiletine—Syncope—Doxorubicin—liver cancer	0.00015	0.00283	CcSEcCtD
Mexiletine—Leukopenia—Doxorubicin—liver cancer	0.000149	0.00282	CcSEcCtD
Mexiletine—Confusional state—Epirubicin—liver cancer	0.000149	0.0028	CcSEcCtD
Mexiletine—Palpitations—Doxorubicin—liver cancer	0.000148	0.00279	CcSEcCtD
Mexiletine—Oedema—Epirubicin—liver cancer	0.000147	0.00278	CcSEcCtD
Mexiletine—Loss of consciousness—Doxorubicin—liver cancer	0.000147	0.00277	CcSEcCtD
Mexiletine—Shock—Epirubicin—liver cancer	0.000145	0.00274	CcSEcCtD
Mexiletine—Convulsion—Doxorubicin—liver cancer	0.000145	0.00273	CcSEcCtD
Mexiletine—Thrombocytopenia—Epirubicin—liver cancer	0.000144	0.00272	CcSEcCtD
Mexiletine—Hypertension—Doxorubicin—liver cancer	0.000144	0.00272	CcSEcCtD
Mexiletine—Hyperhidrosis—Epirubicin—liver cancer	0.000142	0.00269	CcSEcCtD
Mexiletine—Arthralgia—Doxorubicin—liver cancer	0.000142	0.00268	CcSEcCtD
Mexiletine—Chest pain—Doxorubicin—liver cancer	0.000142	0.00268	CcSEcCtD
Mexiletine—Discomfort—Doxorubicin—liver cancer	0.00014	0.00265	CcSEcCtD
Mexiletine—Dry mouth—Doxorubicin—liver cancer	0.000139	0.00262	CcSEcCtD
Mexiletine—Hypotension—Epirubicin—liver cancer	0.000138	0.0026	CcSEcCtD
Mexiletine—Confusional state—Doxorubicin—liver cancer	0.000137	0.00259	CcSEcCtD
Mexiletine—Oedema—Doxorubicin—liver cancer	0.000136	0.00257	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000134	0.00253	CcSEcCtD
Mexiletine—Shock—Doxorubicin—liver cancer	0.000134	0.00253	CcSEcCtD
Mexiletine—Thrombocytopenia—Doxorubicin—liver cancer	0.000133	0.00252	CcSEcCtD
Mexiletine—Paraesthesia—Epirubicin—liver cancer	0.000132	0.0025	CcSEcCtD
Mexiletine—Hyperhidrosis—Doxorubicin—liver cancer	0.000132	0.00249	CcSEcCtD
Mexiletine—Dyspnoea—Epirubicin—liver cancer	0.000131	0.00248	CcSEcCtD
Mexiletine—Somnolence—Epirubicin—liver cancer	0.000131	0.00247	CcSEcCtD
Mexiletine—Dyspepsia—Epirubicin—liver cancer	0.00013	0.00245	CcSEcCtD
Mexiletine—Hypotension—Doxorubicin—liver cancer	0.000127	0.0024	CcSEcCtD
Mexiletine—Fatigue—Epirubicin—liver cancer	0.000127	0.0024	CcSEcCtD
Mexiletine—Pain—Epirubicin—liver cancer	0.000126	0.00238	CcSEcCtD
Mexiletine—Constipation—Epirubicin—liver cancer	0.000126	0.00238	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000124	0.00234	CcSEcCtD
Mexiletine—Paraesthesia—Doxorubicin—liver cancer	0.000122	0.00231	CcSEcCtD
Mexiletine—Dyspnoea—Doxorubicin—liver cancer	0.000122	0.00229	CcSEcCtD
Mexiletine—Feeling abnormal—Epirubicin—liver cancer	0.000121	0.00229	CcSEcCtD
Mexiletine—Somnolence—Doxorubicin—liver cancer	0.000121	0.00229	CcSEcCtD
Mexiletine—Gastrointestinal pain—Epirubicin—liver cancer	0.00012	0.00227	CcSEcCtD
Mexiletine—Dyspepsia—Doxorubicin—liver cancer	0.00012	0.00226	CcSEcCtD
Mexiletine—Fatigue—Doxorubicin—liver cancer	0.000118	0.00222	CcSEcCtD
Mexiletine—Pain—Doxorubicin—liver cancer	0.000117	0.0022	CcSEcCtD
Mexiletine—Constipation—Doxorubicin—liver cancer	0.000117	0.0022	CcSEcCtD
Mexiletine—Abdominal pain—Epirubicin—liver cancer	0.000116	0.0022	CcSEcCtD
Mexiletine—Body temperature increased—Epirubicin—liver cancer	0.000116	0.0022	CcSEcCtD
Mexiletine—Feeling abnormal—Doxorubicin—liver cancer	0.000112	0.00212	CcSEcCtD
Mexiletine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000111	0.0021	CcSEcCtD
Mexiletine—Hypersensitivity—Epirubicin—liver cancer	0.000109	0.00205	CcSEcCtD
Mexiletine—Body temperature increased—Doxorubicin—liver cancer	0.000108	0.00203	CcSEcCtD
Mexiletine—Abdominal pain—Doxorubicin—liver cancer	0.000108	0.00203	CcSEcCtD
Mexiletine—Asthenia—Epirubicin—liver cancer	0.000106	0.002	CcSEcCtD
Mexiletine—Diarrhoea—Epirubicin—liver cancer	0.000101	0.0019	CcSEcCtD
Mexiletine—Hypersensitivity—Doxorubicin—liver cancer	0.0001	0.0019	CcSEcCtD
Mexiletine—Asthenia—Doxorubicin—liver cancer	9.78e-05	0.00185	CcSEcCtD
Mexiletine—Dizziness—Epirubicin—liver cancer	9.74e-05	0.00184	CcSEcCtD
Mexiletine—Vomiting—Epirubicin—liver cancer	9.37e-05	0.00177	CcSEcCtD
Mexiletine—Diarrhoea—Doxorubicin—liver cancer	9.33e-05	0.00176	CcSEcCtD
Mexiletine—Rash—Epirubicin—liver cancer	9.29e-05	0.00175	CcSEcCtD
Mexiletine—Dermatitis—Epirubicin—liver cancer	9.28e-05	0.00175	CcSEcCtD
Mexiletine—Headache—Epirubicin—liver cancer	9.23e-05	0.00174	CcSEcCtD
Mexiletine—Dizziness—Doxorubicin—liver cancer	9.01e-05	0.0017	CcSEcCtD
Mexiletine—Nausea—Epirubicin—liver cancer	8.75e-05	0.00165	CcSEcCtD
Mexiletine—Vomiting—Doxorubicin—liver cancer	8.67e-05	0.00164	CcSEcCtD
Mexiletine—Rash—Doxorubicin—liver cancer	8.59e-05	0.00162	CcSEcCtD
Mexiletine—Dermatitis—Doxorubicin—liver cancer	8.59e-05	0.00162	CcSEcCtD
Mexiletine—Headache—Doxorubicin—liver cancer	8.54e-05	0.00161	CcSEcCtD
Mexiletine—Nausea—Doxorubicin—liver cancer	8.1e-05	0.00153	CcSEcCtD
Mexiletine—Tocainide—ALB—liver cancer	3.33e-05	1	CrCbGaD
Mexiletine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	3.3e-05	0.000447	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	3.27e-05	0.000443	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	3.27e-05	0.000443	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—GSTP1—liver cancer	3.26e-05	0.000441	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	3.25e-05	0.000439	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—HRAS—liver cancer	3.24e-05	0.000438	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—HRAS—liver cancer	3.24e-05	0.000438	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TAT—liver cancer	3.21e-05	0.000435	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	3.21e-05	0.000435	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MMP2—liver cancer	3.21e-05	0.000434	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—VEGFA—liver cancer	3.2e-05	0.000432	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—VEGFA—liver cancer	3.2e-05	0.000432	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—TGFB1—liver cancer	3.19e-05	0.000432	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—STAT3—liver cancer	3.16e-05	0.000428	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—STAT3—liver cancer	3.16e-05	0.000428	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TAT—liver cancer	3.15e-05	0.000426	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—HRAS—liver cancer	3.12e-05	0.000422	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—IL6—liver cancer	3.1e-05	0.000419	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—IL6—liver cancer	3.1e-05	0.000419	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—VEGFA—liver cancer	3.08e-05	0.000417	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—STAT3—liver cancer	3.05e-05	0.000413	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	3.05e-05	0.000412	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—VEGFA—liver cancer	3.04e-05	0.000411	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	3.01e-05	0.000407	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—GSTM1—liver cancer	2.99e-05	0.000405	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—IL6—liver cancer	2.99e-05	0.000404	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—TNF—liver cancer	2.98e-05	0.000403	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—KRAS—liver cancer	2.96e-05	0.0004	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	2.95e-05	0.000399	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—TGFB1—liver cancer	2.93e-05	0.000397	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—TGFB1—liver cancer	2.93e-05	0.000397	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	2.89e-05	0.000391	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—RAF1—liver cancer	2.84e-05	0.000385	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—CYP1A1—liver cancer	2.84e-05	0.000384	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—TGFB1—liver cancer	2.83e-05	0.000383	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GGT1—liver cancer	2.8e-05	0.000379	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	2.8e-05	0.000379	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	2.78e-05	0.000377	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	2.76e-05	0.000373	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—TNF—liver cancer	2.74e-05	0.000371	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—TNF—liver cancer	2.74e-05	0.000371	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—KRAS—liver cancer	2.72e-05	0.000368	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—KRAS—liver cancer	2.72e-05	0.000368	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—TNF—liver cancer	2.64e-05	0.000357	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—KRAS—liver cancer	2.62e-05	0.000355	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—KRAS—liver cancer	2.58e-05	0.000349	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GSTP1—liver cancer	2.51e-05	0.00034	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HRAS—liver cancer	2.51e-05	0.00034	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—UGDH—liver cancer	2.51e-05	0.000339	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	2.48e-05	0.000336	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CTNNB1—liver cancer	2.46e-05	0.000333	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MMP9—liver cancer	2.41e-05	0.000326	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—IL6—liver cancer	2.41e-05	0.000325	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—EPT1—liver cancer	2.36e-05	0.000319	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GSTM1—liver cancer	2.31e-05	0.000313	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HRAS—liver cancer	2.31e-05	0.000313	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—HRAS—liver cancer	2.31e-05	0.000313	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	2.28e-05	0.000308	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TAT—liver cancer	2.23e-05	0.000302	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—HRAS—liver cancer	2.23e-05	0.000301	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—AKT1—liver cancer	2.22e-05	0.0003	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—IL6—liver cancer	2.21e-05	0.000299	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—IL6—liver cancer	2.21e-05	0.000299	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—HRAS—liver cancer	2.19e-05	0.000297	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	2.19e-05	0.000296	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CPT1B—liver cancer	2.18e-05	0.000296	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GLUL—liver cancer	2.18e-05	0.000296	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—VEGFA—liver cancer	2.17e-05	0.000293	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	2.16e-05	0.000292	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—STAT3—liver cancer	2.15e-05	0.00029	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CPT1B—liver cancer	2.14e-05	0.000289	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GLUL—liver cancer	2.14e-05	0.000289	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—IL6—liver cancer	2.13e-05	0.000288	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2.13e-05	0.000288	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—UGDH—liver cancer	2.12e-05	0.000287	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NR1H4—liver cancer	2.11e-05	0.000285	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—IL6—liver cancer	2.1e-05	0.000284	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTA3—liver cancer	2.07e-05	0.00028	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NR1H4—liver cancer	2.06e-05	0.000279	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—AKT1—liver cancer	2.04e-05	0.000276	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—AKT1—liver cancer	2.04e-05	0.000276	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTA3—liver cancer	2.03e-05	0.000274	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—EPT1—liver cancer	2e-05	0.00027	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TGFB1—liver cancer	1.99e-05	0.000269	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—AKT1—liver cancer	1.97e-05	0.000266	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTA4—liver cancer	1.89e-05	0.000256	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TAT—liver cancer	1.89e-05	0.000256	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	1.86e-05	0.000252	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TNF—liver cancer	1.86e-05	0.000251	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTA4—liver cancer	1.85e-05	0.000251	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTA2—liver cancer	1.85e-05	0.00025	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—KRAS—liver cancer	1.84e-05	0.000249	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTA2—liver cancer	1.81e-05	0.000245	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTA1—liver cancer	1.78e-05	0.000241	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NAT2—liver cancer	1.76e-05	0.000238	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTA1—liver cancer	1.74e-05	0.000236	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NAT2—liver cancer	1.72e-05	0.000233	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ALDOB—liver cancer	1.69e-05	0.000228	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ALDOB—liver cancer	1.65e-05	0.000224	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—UGDH—liver cancer	1.64e-05	0.000222	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CRABP1—liver cancer	1.61e-05	0.000218	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CRABP1—liver cancer	1.58e-05	0.000213	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HRAS—liver cancer	1.57e-05	0.000212	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—EPT1—liver cancer	1.54e-05	0.000208	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CPT1B—liver cancer	1.52e-05	0.000205	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GLUL—liver cancer	1.52e-05	0.000205	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—IL6—liver cancer	1.5e-05	0.000203	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NR1H4—liver cancer	1.46e-05	0.000198	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TAT—liver cancer	1.46e-05	0.000198	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTA3—liver cancer	1.44e-05	0.000195	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—HPGDS—liver cancer	1.41e-05	0.00019	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.39e-05	0.000188	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—AKT1—liver cancer	1.38e-05	0.000187	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—HPGDS—liver cancer	1.38e-05	0.000187	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTA4—liver cancer	1.32e-05	0.000178	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GLUL—liver cancer	1.29e-05	0.000174	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CPT1B—liver cancer	1.29e-05	0.000174	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTA2—liver cancer	1.28e-05	0.000174	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PSMA4—liver cancer	1.25e-05	0.00017	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PSMD10—liver cancer	1.25e-05	0.00017	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NR1H4—liver cancer	1.24e-05	0.000168	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTA1—liver cancer	1.24e-05	0.000167	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PSMA4—liver cancer	1.23e-05	0.000166	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PSMD10—liver cancer	1.23e-05	0.000166	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NAT2—liver cancer	1.22e-05	0.000166	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GOT2—liver cancer	1.22e-05	0.000165	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTA3—liver cancer	1.22e-05	0.000165	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GOT2—liver cancer	1.2e-05	0.000162	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ALDOB—liver cancer	1.17e-05	0.000159	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP2E1—liver cancer	1.15e-05	0.000155	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CRABP1—liver cancer	1.12e-05	0.000151	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTA4—liver cancer	1.11e-05	0.000151	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.09e-05	0.000147	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTA2—liver cancer	1.09e-05	0.000147	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYCS—liver cancer	1.07e-05	0.000145	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GGT1—liver cancer	1.05e-05	0.000143	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GOT1—liver cancer	1.05e-05	0.000143	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYCS—liver cancer	1.05e-05	0.000142	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTA1—liver cancer	1.05e-05	0.000142	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NAT2—liver cancer	1.04e-05	0.00014	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GGT1—liver cancer	1.03e-05	0.00014	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GOT1—liver cancer	1.03e-05	0.00014	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.97e-06	0.000135	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ALDOB—liver cancer	9.94e-06	0.000134	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CPT1B—liver cancer	9.92e-06	0.000134	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GLUL—liver cancer	9.92e-06	0.000134	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HPGDS—liver cancer	9.78e-06	0.000132	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NR1H4—liver cancer	9.57e-06	0.000129	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CRABP1—liver cancer	9.48e-06	0.000128	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTP1—liver cancer	9.46e-06	0.000128	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA3—liver cancer	9.41e-06	0.000127	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—HMOX1—liver cancer	9.33e-06	0.000126	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTP1—liver cancer	9.27e-06	0.000125	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—HMOX1—liver cancer	9.14e-06	0.000124	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PSMA4—liver cancer	8.72e-06	0.000118	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PSMD10—liver cancer	8.72e-06	0.000118	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTM1—liver cancer	8.69e-06	0.000118	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA4—liver cancer	8.6e-06	0.000116	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.54e-06	0.000115	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTM1—liver cancer	8.52e-06	0.000115	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GOT2—liver cancer	8.48e-06	0.000115	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA2—liver cancer	8.39e-06	0.000113	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HPGDS—liver cancer	8.29e-06	0.000112	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP1A1—liver cancer	8.24e-06	0.000112	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.24e-06	0.000111	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA1—liver cancer	8.09e-06	0.000109	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP1A1—liver cancer	8.07e-06	0.000109	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NAT2—liver cancer	8e-06	0.000108	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP2E1—liver cancer	7.97e-06	0.000108	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—MTHFR—liver cancer	7.68e-06	0.000104	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALDOB—liver cancer	7.67e-06	0.000104	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PPARA—liver cancer	7.54e-06	0.000102	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—MTHFR—liver cancer	7.53e-06	0.000102	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.5e-06	0.000102	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYCS—liver cancer	7.46e-06	0.000101	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.41e-06	0.0001	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PSMD10—liver cancer	7.39e-06	9.99e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PSMA4—liver cancer	7.39e-06	9.99e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PPARA—liver cancer	7.38e-06	9.99e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GOT1—liver cancer	7.32e-06	9.91e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GGT1—liver cancer	7.32e-06	9.91e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CRABP1—liver cancer	7.32e-06	9.9e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GOT2—liver cancer	7.18e-06	9.72e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP2E1—liver cancer	6.75e-06	9.14e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTP1—liver cancer	6.58e-06	8.9e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.54e-06	8.85e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HMOX1—liver cancer	6.49e-06	8.78e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CG—liver cancer	6.46e-06	8.74e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HPGDS—liver cancer	6.39e-06	8.65e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CG—liver cancer	6.32e-06	8.56e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYCS—liver cancer	6.32e-06	8.55e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PPARG—liver cancer	6.23e-06	8.43e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GGT1—liver cancer	6.2e-06	8.39e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GOT1—liver cancer	6.2e-06	8.39e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PPARG—liver cancer	6.1e-06	8.26e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTM1—liver cancer	6.04e-06	8.18e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP1A1—liver cancer	5.73e-06	7.75e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PSMA4—liver cancer	5.7e-06	7.71e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PSMD10—liver cancer	5.7e-06	7.71e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CD—liver cancer	5.68e-06	7.68e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ALB—liver cancer	5.6e-06	7.58e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTP1—liver cancer	5.57e-06	7.54e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CD—liver cancer	5.56e-06	7.52e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GOT2—liver cancer	5.54e-06	7.5e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HMOX1—liver cancer	5.49e-06	7.43e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ALB—liver cancer	5.49e-06	7.43e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MTHFR—liver cancer	5.34e-06	7.23e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PPARA—liver cancer	5.24e-06	7.09e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP2E1—liver cancer	5.21e-06	7.05e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTM1—liver cancer	5.12e-06	6.93e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CB—liver cancer	4.95e-06	6.69e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYCS—liver cancer	4.88e-06	6.6e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP1A1—liver cancer	4.85e-06	6.57e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CB—liver cancer	4.85e-06	6.56e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GOT1—liver cancer	4.79e-06	6.48e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GGT1—liver cancer	4.79e-06	6.48e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MTHFR—liver cancer	4.52e-06	6.12e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CG—liver cancer	4.49e-06	6.07e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PPARA—liver cancer	4.44e-06	6.01e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PPARG—liver cancer	4.33e-06	5.86e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTP1—liver cancer	4.3e-06	5.82e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HMOX1—liver cancer	4.24e-06	5.74e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.99e-06	5.4e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTM1—liver cancer	3.95e-06	5.35e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CD—liver cancer	3.94e-06	5.34e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ALB—liver cancer	3.89e-06	5.27e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CG—liver cancer	3.8e-06	5.14e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP1A1—liver cancer	3.75e-06	5.07e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PPARG—liver cancer	3.67e-06	4.96e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MTHFR—liver cancer	3.49e-06	4.72e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CB—liver cancer	3.44e-06	4.65e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PPARA—liver cancer	3.43e-06	4.64e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CD—liver cancer	3.34e-06	4.52e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ALB—liver cancer	3.3e-06	4.46e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CA—liver cancer	3.02e-06	4.08e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CA—liver cancer	2.95e-06	4e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.93e-06	3.97e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CB—liver cancer	2.91e-06	3.94e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PPARG—liver cancer	2.83e-06	3.83e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.58e-06	3.49e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALB—liver cancer	2.55e-06	3.45e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—AKT1—liver cancer	2.46e-06	3.33e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—AKT1—liver cancer	2.41e-06	3.27e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CB—liver cancer	2.25e-06	3.04e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CA—liver cancer	2.1e-06	2.84e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.78e-06	2.4e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AKT1—liver cancer	1.71e-06	2.32e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AKT1—liver cancer	1.45e-06	1.96e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.37e-06	1.85e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AKT1—liver cancer	1.12e-06	1.51e-05	CbGpPWpGaD
